Has Patricia McIlrath, DPM received payments from drug or device companies?

Yes. Drug and device makers reported $3,395 in general payments to Patricia McIlrath, DPM across 88 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Patricia McIlrath, DPM did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Patricia McIlrath, DPM come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Patricia McIlrath, DPM

Podiatrist · Reading, PANPI 1548359318

Payments from drug & device makers

$3,395in general payments, 2019–2025

Across 88 payments — averaging $38.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Organogenesis Inc.$1K
Paratek Pharmaceuticals, Inc.$435
Smith+Nephew$429
Treace Medical Concepts, Inc.$273
Nevro Corp.$244
Averitas Pharma Inc.$101
plus $467 from 10 others

What the payments were for

Travel & lodging$160%
Food & beverage$3,27997%
Education$1003%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Organogenesis Inc.	23	$1,445
Paratek Pharmaceuticals, Inc.	21	$435
Smith+Nephew	9	$429
Treace Medical Concepts, Inc.	2	$273
Nevro Corp.	9	$244
Averitas Pharma Inc.	5	$101
Boston Scientific	3	$97
Convatec Inc.	3	$85
Next Science LLC	3	$81
GRT US Holding, Inc.	3	$66
AbbVie(2 entities)	2	$33
ANI Pharmaceuticals, Inc.	1	$31
Aroa Biosurgery Incorporated	1	$23
Orthofix Medical, Inc.	1	$19
Medtronic	1	$17
Avita Medical Americas, LLC	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,395 in reported general payments places this provider in the 80th percentile of 445 podiatrist providers in Pennsylvania.

See all podiatrist providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$89,566

Medicare patients

290

Services billed

1,490

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ammonium Lactate	213	$3,330
Terbinafine Hcl	291	$2,870
CiclopiroxCiclopirox Olamine	49	$1,883
Clotrimazole	96	$1,730
Ketoconazole	41	$1,340
Gabapentin	101	$716
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip	29	$683
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	44	$522
Ciclopirox	25	$489
Mupirocin	37	$342
Meloxicam	63	$157
Diclofenac Sodium	13	$155

Paid to pharmacies, not to this prescriber.